Hostname: page-component-cd9895bd7-hc48f Total loading time: 0 Render date: 2024-12-22T18:30:25.983Z Has data issue: false hasContentIssue false
  • English
  • Français

Combined clozapine and valproic acid treatment-induced agranulocytosis

Published online by Cambridge University Press:  16 April 2020

R. Madeb ,
S. Hirschmann ,
R. Kurs ,
A. Turkie  and
I. Modai
R. Madeb
Affiliation:
Sha’ar Menashe Mental Health Center, Mobile Post Hefer 38814, Hadera, Israel
S. Hirschmann*
Affiliation:
Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel Sha’ar Menashe Mental Health Center, Mobile Post Hefer 38814, Hadera, Israel
R. Kurs
Affiliation:
Sha’ar Menashe Mental Health Center, Mobile Post Hefer 38814, Hadera, Israel
A. Turkie
Affiliation:
Sha’ar Menashe Mental Health Center, Mobile Post Hefer 38814, Hadera, Israel
I. Modai
Affiliation:
Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel Sha’ar Menashe Mental Health Center, Mobile Post Hefer 38814, Hadera, Israel
*
Corresponding author. E-mail address: [email protected] (S. Hirschmann).
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letter to the Editors
Information
European Psychiatry , Volume 17 , Issue 4 , July 2002 , pp. 238 - 239
Copyright
Copyright © Éditions scientifiques et médicales Elsevier SAS 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Acharya, SBussel, JBHematologic toxicity of sodium valproate. J Pediatr Hematol Oncol 2000;22(1):62–5.CrossRefGoogle ScholarPubMed
Facciola, GAvenoso, AScordo, MGMadia, AGVentimiglia, APerucca, ESmall effects of valproic acid on the plasma concentrations of clozapine and its major metabolites in patients with schizophrenic or affective disorders. Ther Drug Monit 1999; 21(3):341–5.CrossRefGoogle ScholarPubMed
Kando, JCTohen, MCastillo, JCentorrino, FConcurrent use of clozapine and valproate in affective and psychotic disorders. J Clin Psychiatry 1994;55:255–7.Google ScholarPubMed
Kishi, TFujita, NKawaguchi, HIshimae, MWatanabe, KTanaka, TBone marrow suppression induced by high dose valproic acid. Arch Dis Child 1994;71(2):153–5.CrossRefGoogle ScholarPubMed
Luchins, DJFatal agranulocytosis in a chronic schizophrenic patient treated with carbamazepine. Am J Psychiatry 1984; 141(5):687–8.Google Scholar
MacDougall, LGPure red cell aplasia associated with sodium valproate therapy. J Am Med Assoc 1982;247(1):53–4.CrossRefGoogle ScholarPubMed
Watts, RGEmanuel, PDZuckerman, KSHoward, THValproic acid-induced cytopenias: evidence for a dose-related suppression of hematopoiesis. J Pediatr 1990;117(3):495–9.CrossRefGoogle ScholarPubMed
Wilson, WDo anticonvulsants hinder clozapine treatment. Biol Psychiatry 1995;37:132–3.CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.